Resources from the same session
807MO - High efficacy and safety of interleukin-6-knockdown CD19-targeted CAR-T cells in relapsed/refractory B-ALL patients
Presenter: Lei Yu
Session: Mini oral session 1: Haematological malignancies
Resources:
Abstract
Slides
Webcast
808MO - Value of early post-treatment FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T cell therapy
Presenter: Patrick Veit-haibach
Session: Mini oral session 1: Haematological malignancies
Resources:
Abstract
Webcast